⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AZN News
AstraZeneca PLC
Biologics CDMO (2026-2031) - Growing Biologics Pipeline Drives Demand for Outsourced Development and Manufacturing
globenewswire.com
NVO
TMO
ABBV
CAT
EXEL
REGN
BMY
PFE
MRK
AMGN
GILD
BIIB
ISRG
CRSP
EDIT
NTLA
VRTX
AZN
SNY
LLY
JNJ
XOM
CVX
Global Small Molecule Drug Discovery Market (2026-2031) - Rising Pharmaceutical R&D Investment Drives Growth
globenewswire.com
AZN
EVO
EXEL
ICLR
LAB
PFE
RXRX
RLAY
TMO
Multispecific Antibodies Market Report 2026: Forecast to Reach $60 Billion by 2031, Driven by Expanding Clinical Pipeline and Proprietary Technologies
globenewswire.com
AMGN
JNJ
PFE
REGN
MRK
ABBV
BMY
GILD
AZN
XNCR
GEN
ABL
Global Immunomodulators 2026-2031 - Rising Prevalence of Autoimmune Diseases Drives Market Growth
globenewswire.com
BMY
NVS
MRK
AMGN
PFE
LLY
BIIB
AZN
GILD
ABBV
TMO
REGN
IMUX
Dyspnea Treatment Market 2026-2031 - Rising Prevalence of Respiratory and Cardiovascular Diseases to Drive Growth
globenewswire.com
PFE
AZN
TEVA
AMRX
BHC
Pulmonary Edema (2026-2031) - Rising Prevalence of Cardiovascular Diseases Drives Market Growth
globenewswire.com
ABBV
AZN
BSX
BMY
EL
LLY
JNJ
MRK
NVS
PFE
SNY
VTRS
Upper Respiratory Tract Infection Treatment (2026-2031) - Rising Prevalence of Respiratory Infections Drives Market Growth
globenewswire.com
ABT
ABBV
ALC
AZN
BMY
CI
DDS
JNJ
MRK
NVS
PFE
SNY
TEVA
VTRS
Global Cardiometabolic Drugs 2026-2031 - Rising Cardiometabolic Disease Prevalence Drives Market Growth
globenewswire.com
LLY
NVO
AZN
BMY
PFE
MRK
AMGN
ABBV
GILD
Keymed Biosciences Announces 2026 H1 Results and Business Updates
prnewswire.com
AZN
Global PARP Inhibitors Cancer Therapy Market Report 2026: Approved Therapies Dosage, Price, Sales & Clinical Trials Insight 2031
globenewswire.com
AZN
PFE
GSK
BMY
ABBV